Chris Stockmann
Overview
Explore the profile of Chris Stockmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
2239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stockmann C, Olson J, Rashid J, Lubsch L, Young D, Hersh A, et al.
J Clin Pharmacol
. 2018 Oct;
59(2):198-205.
PMID: 30371946
The prevalence of pulmonary methicillin-resistant Staphylococcus aureus infections in patients with cystic fibrosis (CF) has increased over the last 2 decades. Two concentrations-a postdistributive and a trough-are currently used to...
2.
Adler F, Stockmann C, Ampofo K, Pavia A, Byington C
PLoS One
. 2018 Jul;
13(7):e0199388.
PMID: 30044794
Background: Common cold viruses create significant health and financial burdens, and understanding key loci of transmission would help focus control strategies. This study (1) examines factors that influence when individuals...
3.
Frymoyer A, Stockmann C, Hersh A, Goswami S, Keizer R
J Pediatric Infect Dis Soc
. 2018 Jan;
8(2):97-104.
PMID: 29294072
Background: Vancomycin dosing in neonates is challenging because of the large variation in pharmacokinetics. Existing empiric dosing recommendations use table-based formats, within which a neonate is categorized on the basis...
4.
Rower J, Stockmann C, Linakis M, Kumar S, Liu X, Korgenski E, et al.
BMJ Paediatr Open
. 2017 Nov;
1:e000147.
PMID: 29177199
Objective: Immunosuppressant therapy plays a pivotal role in transplant success and longevity. Tacrolimus, a primary immunosuppressive agent, is well known to exhibit significant pharmacological interpatient and intrapatient variability. This variability...
5.
Lu X, Schneider E, Jain S, Bramley A, Hymas W, Stockmann C, et al.
J Infect Dis
. 2017 Oct;
216(9):1104-1111.
PMID: 28968668
Background: Rhinoviruses (RVs) are ubiquitous respiratory pathogens that often cause mild or subclinical infections. Molecular detection of RVs from the upper respiratory tract can be prolonged, complicating etiologic association in...
6.
Schlaberg R, Ampofo K, Tardif K, Stockmann C, Simmon K, Hymas W, et al.
J Infect Dis
. 2017 Sep;
216(6):688-696.
PMID: 28934425
Background: The role of human bocavirus (HBoV) in respiratory illness is uncertain. HBoV genomic DNA is frequently detected in both ill and healthy children. We hypothesized that spliced viral capsid...
7.
Hamdy R, Hsu A, Stockmann C, Olson J, Bryan M, Hersh A, et al.
Pediatrics
. 2017 Jun;
139(6).
PMID: 28562284
Background: Methicillin-resistant (MRSA) bacteremia is associated with high rates of treatment failure in adults. The epidemiology, clinical outcomes, and risk factors for treatment failure associated with MRSA bacteremia in children...
8.
Hersh A, Olson J, Stockmann C, Thorell E, Knackstedt E, Esquibel L, et al.
J Pediatric Infect Dis Soc
. 2017 May;
7(2):e34-e36.
PMID: 28549165
We developed an outpatient parenteral antibiotic therapy (OPAT) stewardship program in a freestanding children's hospital to improve the appropriateness of OPAT prescribing. Introduction of the program enabled expert review of...
9.
Bramley A, Reed C, Finelli L, Self W, Ampofo K, Arnold S, et al.
J Infect Dis
. 2017 May;
215(12):1873-1882.
PMID: 28520948
Background: The effect of body mass index (BMI) on community-acquired pneumonia (CAP) severity is unclear. Methods: We investigated the relationship between BMI and CAP outcomes (hospital length of stay [LOS],...
10.
Schlaberg R, Queen K, Simmon K, Tardif K, Stockmann C, Flygare S, et al.
J Infect Dis
. 2017 Apr;
215(9):1407-1415.
PMID: 28368491
Background: Community-acquired pneumonia (CAP) is a leading cause of pediatric hospitalization. Pathogen identification fails in approximately 20% of children but is critical for optimal treatment and prevention of hospital-acquired infections....